A class action lawsuit has been filed against Bloom Energy Corporation by investors who bought its securities between February 27, 2025, and July 8, 2026. The suit alleges that Bloom Energy failed to disclose its reliance on scandium sourced from China through intermediaries, misleading investors about the extent of this dependency. This came to light after a media report on July 8, 2026, revealed the company's reliance on Chinese scandium. Investors who suffered losses during this period are encouraged to join the lawsuit, with a deadline to move for lead plaintiff status by September 28, 2026.
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...
